Home » Topics » Disease categories and therapies » Infection

Infection
RSS

New antiviral agents from SB for herpesvirus infections

Feb. 9, 1999

Novel semisynthetic macrolide antibiotics developed at Abbott

Feb. 5, 1999

Pediatric use of Maxipime approved by the FDA

Feb. 3, 1999

9a-Azalides with potent antibacterial activity in development at Merck

Feb. 2, 1999

Bayer describes new oxazolidinone antibacterials in recently issued patent

Feb. 2, 1999

Regulatory plans for gatifloxacin outlined by Kyorin

Feb. 1, 1999

Daiichi patents broad-spectrum antibacterial series

Feb. 1, 1999

Canadian company formed to develop nucleic acid-based antiinfective drugs

Jan. 29, 1999

FDA advisory committee scheduled to discuss Relenza NDA

Jan. 29, 1999

Broad-spectrum antibacterial agents discovered at Daiichi

Jan. 29, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026